NASDAQ:HALO | Debt/Equity Ratio | HALOZYME THERAPEUTICS, INC.

Complete source-backed debt/equity ratio history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-3014.95
2026-03-319.76
2025-12-3143.89
2025-09-303
2024-12-314.14
2023-12-3117.89
2023-09-306.01
2023-06-309.91
2023-03-3122.69
2022-12-318.87
2022-09-3015.51
2022-06-304.25
2022-03-313.37
2021-12-314.45
2021-09-303.11
2021-06-307.3
2021-03-3112.93
2020-12-312.63
2020-09-303.98
2020-06-303.69
2020-03-316.71
2019-12-314.39
2019-09-300.26
2019-06-300.33
2019-03-310.41
2018-12-310.51
2018-09-300.61
2018-06-300.65
2018-03-310.7
2017-12-310.97
2017-09-302.86
2017-06-303.63
2017-03-31-3.66
2016-12-31-6.67
2016-09-30-17.69
2016-06-3020.98
2016-03-316.65
2015-12-311.16
2015-09-301.57
2015-06-300.99
2015-03-311.32
2014-12-311.21
2014-09-301.25
2014-06-300.9
2014-03-310.75
2013-12-31-2.49
2013-09-30-8.53
2013-06-302.67
2013-03-310.94
2012-12-310.61

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-3143.89
2024-12-314.14
2023-12-3117.89
2022-12-318.87
2021-12-314.45
2020-12-312.63
2019-12-314.39
2018-12-310.51
2017-12-310.97
2016-12-31-6.67
2015-12-311.16
2014-12-311.21
2013-12-31-2.49
2012-12-310.61